Hoyoung Huh
Independent Chairman & Lead DirectorDr. Hoyoung Huh, M.D., Ph.D., was Special Advisor to Chief Executive Officer of CytomX Therapeutics, Inc. from December 31, 2018. Dr. Huh is Independent Chairman & Lead Director of Pliant Therapeutics, Inc. since December 2017. He is founder of Peak Bio Inc. (f/k/a pH Pharma) and has held positions of Chief Executive Officer and Board Chairman since founding pH Pharma in 2015. Dr. Huh is a Silicon Valley-based entrepreneur and investor in healthcare and technology-based businesses. He previously served as the Chairman of the board of directors of Geron Corporation from September 2011 to December 2018. Dr. Huh is Independent Chairman of Akari Therapeutics, Plc since November 14, 2024. Dr. Huh was Chairman of CytomX Therapeutics, Inc. from February 2012 to December 31, 2018. Dr. Huh joined the CytomX Therapeutics, Inc. in December 2011 and served as a member of the board of directors of Rezolute, Inc. (f/k/a AntriaBio, Inc.) from 2013 to January 2019. Dr. Huh is also the founder of Healthcare & Humanity Foundation. Dr. Huh was a Managing Director of Konus Advisory Group, Inc. from January 2012 to September 2014. Prior to founding Konus Advisory Group, Inc., Dr. Huh was Chief Executive Officer and Chairman of the board of directors of BiPar Sciences, Inc. from February 2008 until December 2010. Dr. Huh has M.D. from Cornell University Medical College. Dr. Huh has B.S. in Biochemistry from Dartmouth College. Dr. Huh has B.A. in Economics, Biochemistry from Dartmouth College. Dr. Huh has Ph.D. in Cellular Biology, Cellular Biology, Genetics, Genetics from Cornell University Sloan Kettering Institute.
Positions
- Company NamePliant Therapeutics, Inc.Stock CodePLRXPositionIndependent Chairman & Lead DirectorColleagues
- BJBernard Jozef CouliePresident, CEO & Director
- HHHoyoung HuhIndependent Chairman & Lead Director
- KLKeith Lamont CummingsChief Financial Officer
- MKMinnie KuoChief Operating Officer
- RDRik DerynckScientific Founder & Member of Scientific Advisory Board
- DSDean SheppardScientific Founder & Member of Scientific Advisory Board
- HCHal ChapmanScientific Founder & Member of Scientific Advisory Board
- Company NameAkari Therapeutics, PlcStock CodeAKTXPositionIndependent ChairmanColleagues
- AGAbizer GaslightwalaCEO, President & Director
- KDKameel D. FaragInterim Chief Financial Officer
- SMSatyajit MitraExecutive Director & Head of Oncology
- VVVatnak Vat-HoChief Business Officer
- RBRobert B. BazemoreIndependent Director
- SISandip Indravadan PatelIndependent Director
- RPRaymond Prudo-ChleboszIndependent Director
